Bottle of Lies: The Inside Story of the Generic Drug Boom

Nonfiction | Book | Adult | Published in 2019

A modern alternative to SparkNotes and CliffsNotes, SuperSummary offers high-quality Study Guides with detailed chapter summaries and analysis of major themes, characters, and more.

Download PDF

Study Guide

Before You Read Beta

Summary

Background

Chapter Summaries & Analyses

Prologue

Part 1

Part 2

Part 3

Part 4

Part 5

Part 6

Part 7

Epilogue

Key Figures

Themes

Index of Terms

Important Quotes

Essay Topics

Tools Beta

Discussion Questions

EpilogueChapter Summaries & Analyses

Epilogue Summary

Eban describes the aftermath of the Ranbaxy case. Peter Baker, Thakur, and others who investigated generic drugs continued to avoid generics in their own lives and advised others to do the same. Thakur and Sonal were not able to repair their marriage and eventually divorced. Peter Baker relocated to China, and uncovered similar operations to the ones he observed in India: secondary manufacturing operations that tested and manufactured drugs in parallel to the official pharmaceutical facilities.

The Ranbaxy company no longer exists, and Daiichi Sankyo won its case against Malvinder Singh.

The FDA continued to find issues with Mylan’s plants.

After Lal was removed from his position at the FDA, the FDA resumed its previous method of inspections: announcing them in advance.

Epilogue Analysis

The Epilogue of Bottle of Lies encapsulates the enduring impact of the Ranbaxy case on key individuals, the pharmaceutical industry, and regulatory practices.

The aftermath of the Ranbaxy case is marked by a lasting skepticism toward generic drugs among investigators like Peter Baker and Dinesh Thakur. Their personal avoidance of generics and advice to others reflect their deep-seated concerns regarding the integrity of